Mixed Results for Paxlovid in Standard Risk Patients With COVID-19
The study evaluated Paxlovid in both vaccinated and unvaccinated patients with COVID-19 at standard risk for progressing to severe disease.
COVID19
ADA: Diabetes May Quadruple Risk for Long COVID
Authors say review findings are limited by heterogenous definitions of long COVID in published studies
ASCO: Increase in Cancer-Related Death Seen During Pandemic
Cancer-related monthly mortality rate higher in April 2020 when health care capacity was most challenged
Two New Omicron Subvariants Gain Ground in the US
Subvariants now account for 13% of new coronavirus cases nationwide compared with 7.5% a few weeks ago.
More Clinical Benefits of Molnupiravir ID’d in COVID-19
Compared with placebo, normalization of C-reactive protein and oxygen saturation faster, with improvements seen on day 3 of treatment
Vaccination Status Affects Patient Willingness to Have Surgery During Pandemic
In hypothetical scenarios for a viral pandemic, willingness for surgery was higher with both patients and hospital staff vaccinated
Multisystem Abnormalities Persist After COVID-19 Hospitalization
Persisting evidence of cardio-renal involvement, hemostasis pathway activation reported at 28 to 60 days after discharge
Post-COVID Conditions Are Common Among Adult Survivors
More than 2-fold risk of acute pulmonary embolism and respiratory signs and symptoms among survivors aged 18 to 64, ≥65 years
US Making It Easier to Access COVID-19 Treatment Paxlovid
First test-to-treat site backed by the federal government is opening in Rhode Island
Psychological Distress May Increase Risk for COVID-19 Hospitalization
Depression, worry about COVID-19, loneliness as strongly linked to hospitalization as high cholesterol, hypertension
- Loading...
Loading...
Next post in Men's Health Update
Loading... 
Loading...